When the buprenorphine dose is insufficient plus the CYP3A4 inducer can not be lessened or discontinued, changeover the patient again to some buprenorphine formulation that allows dose adjustments. pentobarbital will reduce the level or influence of losartan by impacting hepatic enzyme CYP2C9/ten metabolism. Minimal/Significance Mysterious. U